FDA Requires Additional Information On DORIBAX For Treatment Of Hospital-Acquired Pneumonia (Medical News Today)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced that the U.S.

FDA To Strengthen Warnings On Diabetes Drug After 2 More Deaths (Medical News Today)
Futher to an alert it issued in October 2007, the US Food and Drug Administration (FDA) is planning to strengthen the warnings on diabetes drug Byetta (exenatide) after receiving reports of another 6 patients having to be admitted to hospital, two of whom died, because they got hemorrhagic or necrotizing pancreatitis after taking the drug.